Management and Epidemiology of Gastric Intestinal Metaplasia
Summary
Gastric intestinal metaplasia (GIM) represents a crucial pre-neoplastic alteration of the gastric mucosa in which normal gastric epithelium is replaced by an intestinal phenotype. It often arises in the context of chronic Helicobacter pylori infection and progressive atrophic gastritis. The global prevalence of GIM varies widely, with higher rates reported in regions of elevated gastric cancer incidence such as East Asia and parts of Eastern Europe. Key risk factors include prolonged H. pylori colonisation, advanced age, male sex and environmental influences such as diet and smoking. Histological subtyping distinguishes complete metaplasia, which resembles small-intestinal epithelium, from incomplete metaplasia, which retains both gastric and intestinal features and carries a significantly greater risk of progression to dysplasia and adenocarcinoma. Management strategies centre on eradication of H. pylori, periodic endoscopic surveillance guided by staging systems, and targeted biopsy protocols to identify focal dysplasia. Advances in molecular profiling and non-invasive biomarkers are refining risk stratification, enabling more precise allocation of surveillance intervals and preventive interventions. Integration of clinical, histological and emerging genomic data is increasingly informing personalised approaches to intercept progression from GIM to gastric malignancy.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Management and Epidemiology of Gastric Intestinal Metaplasia publication trend
The graph below shows the total number of articles in management and epidemiology of gastric intestinal metaplasia across all publications each year (not limited to Nature Index journals).
Technical terms
Gastric intestinal metaplasia (GIM): Replacement of gastric epithelium by cells resembling those of the intestine, a recognised precursor to gastric cancer.
Incomplete metaplasia: A histological subtype of GIM retaining gastric mucin production alongside intestinal features, associated with higher malignant potential.
Endoscopic surveillance: Scheduled gastroscopic examinations with systematic biopsies to monitor progression of precancerous gastric lesions.
Helicobacter pylori eradication: Use of antibiotic regimens to eliminate H. pylori infection, shown to reduce incidence and progression of gastric precancerous conditions.
Biomarker: A measurable molecular indicator—such as OLFM4 expression—used to detect disease state or predict progression risk in gastric metaplasia.
References
- OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway. Molecular Cancer (2024).
- Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression. Cancer Cell (2023).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.